HK1253918A1 - 可吸入腎上腺素 - Google Patents
可吸入腎上腺素Info
- Publication number
- HK1253918A1 HK1253918A1 HK18113066.2A HK18113066A HK1253918A1 HK 1253918 A1 HK1253918 A1 HK 1253918A1 HK 18113066 A HK18113066 A HK 18113066A HK 1253918 A1 HK1253918 A1 HK 1253918A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- inhalable
- epinephrine
- inhalable epinephrine
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0091—Inhalators mechanically breath-triggered
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2202/00—Special media to be introduced, removed or treated
- A61M2202/06—Solids
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Otolaryngology (AREA)
- Emergency Medicine (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Anesthesiology (AREA)
- Immunology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US39300702P | 2002-06-28 | 2002-06-28 | |
US39371602P | 2002-07-02 | 2002-07-02 | |
US42534902P | 2002-11-08 | 2002-11-08 |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1253918A1 true HK1253918A1 (zh) | 2019-07-05 |
Family
ID=30003840
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK18113066.2A HK1253918A1 (zh) | 2002-06-28 | 2018-10-25 | 可吸入腎上腺素 |
Country Status (13)
Country | Link |
---|---|
US (5) | US7947742B2 (zh) |
EP (2) | EP1531794B1 (zh) |
AU (1) | AU2003280102B2 (zh) |
CA (1) | CA2488976C (zh) |
CY (1) | CY1119481T1 (zh) |
DK (1) | DK1531794T3 (zh) |
ES (2) | ES2867378T3 (zh) |
HK (1) | HK1253918A1 (zh) |
HU (1) | HUE033319T2 (zh) |
LT (1) | LT1531794T (zh) |
PT (1) | PT1531794T (zh) |
SI (1) | SI1531794T1 (zh) |
WO (1) | WO2004002551A2 (zh) |
Families Citing this family (93)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9006175B2 (en) | 1999-06-29 | 2015-04-14 | Mannkind Corporation | Potentiation of glucose elimination |
DE60318938T2 (de) | 2002-03-20 | 2009-01-22 | Mannkind Corp., Valencia | Inhalationsgerät |
CA2488976C (en) * | 2002-06-28 | 2009-08-25 | Advanced Inhalation Research, Inc. | Inhalable epinephrine |
WO2004073729A1 (ja) | 2003-02-21 | 2004-09-02 | Translational Research Ltd. | 薬物の経鼻投与用組成物 |
EP1607117A4 (en) | 2003-03-27 | 2007-10-24 | Bioactis Ltd | APPLICATOR FOR POWDER MEDICATION IN THE NOSE CAVE |
WO2006016530A1 (ja) * | 2004-08-10 | 2006-02-16 | Translational Research, Ltd. | 速効性でかつ高い吸収性を可能とする経鼻投与用組成物 |
ES2385934T3 (es) | 2004-08-20 | 2012-08-03 | Mannkind Corporation | Catálisis de la síntesis de dicetopiperazina. |
EP2314298B1 (en) | 2004-08-23 | 2015-05-27 | MannKind Corporation | Microparticles comprising diketopiperazine salts for drug delivery |
US20060105051A1 (en) * | 2004-11-18 | 2006-05-18 | Blair Jackson | Manufacture of particles for pulmonary drug delivery by carbon dioxide assisted nebulization |
WO2006130943A1 (en) * | 2005-06-10 | 2006-12-14 | The Governors Of The University Of Alberta | Respirable dried powder formulation comprising drug loaded nanoparticles |
US9877921B2 (en) | 2005-09-09 | 2018-01-30 | Nova Southeastern University | Epinephrine nanoparticles, methods of fabrication thereof, and methods for use thereof for treatment of conditions responsive to epinephrine |
US20160045457A1 (en) | 2005-09-09 | 2016-02-18 | Ousama Rachid | Epinephrine fine particles and methods for use thereof for treatment of conditions responsive to epinephrine |
KR20160022404A (ko) | 2005-09-14 | 2016-02-29 | 맨카인드 코포레이션 | 활성제에 대한 결정질 미립자 표면의 친화력의 증가를 기반으로 하는 약물 제제화의 방법 |
ITMI20051999A1 (it) | 2005-10-21 | 2007-04-22 | Eratech S R L | Formulazioni inalatorie di farmaci in fora di polvere secca per somministrazione come tale o con nebulizzatore e dotate di elevata erogabilita' respirabilita' e stabilita' |
MX2008010721A (es) | 2006-02-22 | 2008-09-01 | Mannkind Corp | Un metodo para mejorar las propiedades farmaceuticas de microparticulas que contienen dicetopiperazina y un agente activo. |
WO2008078730A1 (ja) | 2006-12-26 | 2008-07-03 | Translational Research, Ltd. | 経鼻投与用製剤 |
WO2008089485A2 (en) * | 2007-01-19 | 2008-07-24 | The Cleveland Clinic Foundation | Carboxyethylpyrrole compounds and methods of their production |
WO2009088553A1 (en) * | 2007-10-22 | 2009-07-16 | Board Of Regents, The University Of Texas System | Dry powder drug delivery formulations, methods of use, and devices therefore |
EP3281663B8 (en) | 2008-06-13 | 2022-09-21 | MannKind Corporation | Breath powered dry powder inhaler for drug delivery |
US8485180B2 (en) | 2008-06-13 | 2013-07-16 | Mannkind Corporation | Dry powder drug delivery system |
MX2010014240A (es) | 2008-06-20 | 2011-03-25 | Mankind Corp | Un metodo y aparato interactivo para perfilar en tiempo real esfuerzos de inhalacion. |
TWI614024B (zh) | 2008-08-11 | 2018-02-11 | 曼凱公司 | 超快起作用胰島素之用途 |
US8314106B2 (en) | 2008-12-29 | 2012-11-20 | Mannkind Corporation | Substituted diketopiperazine analogs for use as drug delivery agents |
CA2754595C (en) | 2009-03-11 | 2017-06-27 | Mannkind Corporation | Apparatus, system and method for measuring resistance of an inhaler |
RU2577698C2 (ru) | 2009-03-26 | 2016-03-20 | Пулмэтрикс, Инк. | Сухие порошкообразные составы и способы лечения легочных заболеваний |
US9101539B2 (en) * | 2009-05-15 | 2015-08-11 | Shin Nippon Biomedical Laboratories, Ltd. | Intranasal pharmaceutical compositions with improved pharmacokinetics |
US8551528B2 (en) | 2009-06-12 | 2013-10-08 | Mannkind Corporation | Diketopiperazine microparticles with defined specific surface areas |
WO2011013003A2 (en) * | 2009-07-31 | 2011-02-03 | Shin Nippon Biomedical Laboratories, Ltd. | Intranasal granisetron and nasal applicator |
EP2496295A1 (en) | 2009-11-03 | 2012-09-12 | MannKind Corporation | An apparatus and method for simulating inhalation efforts |
US10350364B2 (en) | 2009-11-11 | 2019-07-16 | Windgap Medical, Inc. | Portable Drug Mixing and Delivery Device and Associated Methods |
US20120322884A1 (en) * | 2010-03-01 | 2012-12-20 | University Of Manitoba | Epinephrine nanoparticles, methods of fabrication thereof, and methods for use thereof for treatment of conditions responsive to epinephrine |
BR112012033060A2 (pt) | 2010-06-21 | 2018-02-27 | Mannkind Corp | métodos de sistema de liberação de fármaco em pó seco |
JP5877201B2 (ja) | 2010-08-30 | 2016-03-02 | パルマトリックス,インコーポレイテッド | 肺疾患を治療するための乾燥粉末製剤および方法 |
CN103228273B (zh) * | 2010-09-29 | 2017-04-05 | 普马特里克斯营业公司 | 吸入用单价金属阳离子干粉剂 |
DK2621488T3 (en) | 2010-09-29 | 2019-03-04 | Pulmatrix Operating Co Inc | CATIONIC DRY POWDER |
KR101940832B1 (ko) | 2011-04-01 | 2019-01-21 | 맨카인드 코포레이션 | 의약 카트리지용 블리스터 패키지 |
WO2012174472A1 (en) | 2011-06-17 | 2012-12-20 | Mannkind Corporation | High capacity diketopiperazine microparticles |
US20140242177A1 (en) | 2011-10-21 | 2014-08-28 | Nova Southeastern University | Epinephrine nanoparticles, methods of fabrication thereof, and methods for use thereof for treatment of conditions responsive to epinephrine |
EP2776053A1 (en) | 2011-10-24 | 2014-09-17 | MannKind Corporation | Methods and compositions for treating pain |
CA2865972C (en) | 2012-02-29 | 2022-01-04 | Pulmatrix, Inc. | Inhalable dry powders |
CA2876883C (en) | 2012-06-15 | 2022-11-01 | Nova Southeastern University | Epinephrine nanoparticles, methods of fabrication thereof, and methods for use thereof for treatment of conditions responsive to epinephrine |
US9789071B2 (en) | 2012-06-27 | 2017-10-17 | G2B Pharma, Inc. | Intranasal formulation of epinephrine for the treatment of anaphylaxis |
SG11201500218VA (en) | 2012-07-12 | 2015-03-30 | Mannkind Corp | Dry powder drug delivery systems and methods |
EP2911690A1 (en) | 2012-10-26 | 2015-09-02 | MannKind Corporation | Inhalable influenza vaccine compositions and methods |
WO2014074797A1 (en) | 2012-11-09 | 2014-05-15 | Civitas Therapeutics, Inc. | Ultra low density pulmonary powders |
WO2014127018A1 (en) * | 2013-02-12 | 2014-08-21 | Ys Pharmtech | Epinephrine formulations for medicinal products |
US9867931B2 (en) | 2013-10-02 | 2018-01-16 | Cook Medical Technologies Llc | Therapeutic agents for delivery using a catheter and pressure source |
US11931227B2 (en) | 2013-03-15 | 2024-03-19 | Cook Medical Technologies Llc | Bimodal treatment methods and compositions for gastrointestinal lesions with active bleeding |
US10391262B2 (en) | 2014-03-18 | 2019-08-27 | Windgap Medical, Inc. | Removable actuating cap for use with an auto-injector assembly |
US10569017B2 (en) | 2013-03-15 | 2020-02-25 | Windgap Medical, Inc. | Portable drug mixing and delivery device and associated methods |
WO2014146060A1 (en) | 2013-03-15 | 2014-09-18 | Windgap Medical, Inc. | Portable drug mixing and delivery system and method |
EP3587404B1 (en) | 2013-03-15 | 2022-07-13 | MannKind Corporation | Microcrystalline diketopiperazine compositions, methods for preparation and use thereof |
US9907910B2 (en) | 2013-03-15 | 2018-03-06 | Windgap Medical, Inc. | Portable drug mixing and delivery device and associated methods |
PT2976072T (pt) | 2013-03-22 | 2021-08-12 | Univ Nova Southeastern | Partículas finas de epinefrina e métodos de utilização das mesmas para o tratamento de afeções que reagem à epinefrina |
CA2907566C (en) | 2013-04-01 | 2023-08-22 | Pulmatrix, Inc. | Tiotropium dry powders |
TWI659209B (zh) * | 2013-06-17 | 2019-05-11 | 地平線罕見醫學製藥有限責任公司 | 分析半胱胺組合物的方法 |
BR122019026637B1 (pt) | 2013-07-18 | 2023-09-26 | Mannkind Corporation | Formulações farmacêuticas de pó seco e método para a fabricação de uma formulação de pó seco |
CA2920488C (en) | 2013-08-05 | 2022-04-26 | Mannkind Corporation | Insufflation apparatus and methods |
CA2923270A1 (en) * | 2013-09-03 | 2015-03-12 | Shin Nippon Biomedical Laboratories Ltd. (Snbl) | Intranasal formulation for the treatment of cardiopulmonary resuscitation (cpr), cardiac life support (cls), anaphylaxis and/or anaphylactoid reactions |
BR112016007328A2 (pt) * | 2013-10-03 | 2017-08-01 | Imprimis Pharmaceuticals Inc | composições oftálmicas baseadas em epinefrina para administração intraocular e métodos para fabricar as mesmas |
EP3079743B1 (en) * | 2013-12-11 | 2022-08-03 | De Motu Cordis Pty. Ltd. | Apparatus |
JP2017503017A (ja) * | 2013-12-18 | 2017-01-26 | ウィンドギャップ メディカル, インコーポレイテッド | 薬物混合および送達システムならびに方法 |
WO2015148905A1 (en) | 2014-03-28 | 2015-10-01 | Mannkind Corporation | Use of ultrarapid acting insulin |
US9925335B2 (en) | 2014-08-18 | 2018-03-27 | Windgap Medical, Inc | Portable drug mixing and delivery device and associated methods |
US11116903B2 (en) | 2014-08-18 | 2021-09-14 | Windgap Medical, Inc | Compression seal for use with a liquid component storage vial of an auto-injector |
US20160051494A1 (en) * | 2014-08-21 | 2016-02-25 | Mylan, Inc. | Multi-dose medication kit for treating anaphylaxis |
US10561806B2 (en) | 2014-10-02 | 2020-02-18 | Mannkind Corporation | Mouthpiece cover for an inhaler |
MA40910A (fr) | 2014-11-07 | 2017-09-12 | Civitas Therapeutics Inc | Poudres de rapamycine pour administration pulmonaire |
WO2016100949A2 (en) * | 2014-12-18 | 2016-06-23 | Windgap Medical, Inc. | Method and compositions for dissolving or solubilizing therapeutic agents |
CA2991108A1 (en) | 2015-07-02 | 2017-01-05 | Civitas Therapeutics, Inc. | Triptan powders for pulmonary delivery |
EP3313478B1 (en) | 2015-08-13 | 2020-11-04 | Windgap Medical, Inc. | Mixing and injection device with sterility features |
US10973781B2 (en) * | 2015-09-18 | 2021-04-13 | Hikma Pharmaceuticals Usa Inc. | Epinephrine spray formulations |
US11517525B2 (en) * | 2015-09-18 | 2022-12-06 | Hikma Pharmaceuticals Usa Inc. | Epinephrine spray formulations |
US11571384B2 (en) * | 2015-09-18 | 2023-02-07 | Hikma Pharmaceuticals Usa Inc. | Epinephrine spray formulations |
WO2017087888A1 (en) | 2015-11-18 | 2017-05-26 | President And Fellows Of Harvard College | Systems and methods for monitoring, managing, and treating asthma and anaphylaxis |
CA3034640A1 (en) * | 2016-08-25 | 2018-03-01 | Imprimis Pharmaceuticals, Inc. | Epinephrine-based ophthalmic compositions for intraocular administration and methods for fabricating thereof |
CN111050760A (zh) * | 2017-04-17 | 2020-04-21 | 希克玛制药美国公司 | 肾上腺素喷雾制剂 |
US11744967B2 (en) | 2017-09-26 | 2023-09-05 | Shin Nippon Biomedical Laboratories, Ltd. | Intranasal delivery devices |
JP7335263B2 (ja) * | 2017-12-21 | 2023-08-29 | キウィタス セラピューティクス,インコーポレイテッド | 吸入のための界面活性剤製剤 |
WO2019182745A1 (en) * | 2018-03-19 | 2019-09-26 | Bryn Pharma, LLC | Epinephrine spray formulations |
CA3093725C (en) | 2018-03-23 | 2021-08-24 | Nevakar Inc. | Epinephrine compositions and containers |
PL3829551T3 (pl) | 2018-07-30 | 2024-04-02 | Biothea Pharma, Inc. | Krystaliczna sól malonianu epinefryny |
US11433063B1 (en) | 2019-03-12 | 2022-09-06 | Belhaven Biopharma, Inc. | Intranasal composition of pharmaceutical countermeasures for chemical warfare nerve agents and accidental exposure to organophosphate pesticides |
RS63725B1 (sr) | 2020-05-18 | 2022-12-30 | Orexo Ab | Nova farmaceutska kompozicija za davanje leka |
KR20230165764A (ko) | 2021-03-23 | 2023-12-05 | 1232176 비.씨. 리미티드 | 아나필락시스를 치료하기 위한 디바이스 |
WO2022256379A1 (en) * | 2021-06-03 | 2022-12-08 | Michael Ogburn | Inhalable pharmaceutical formulations |
US11617716B2 (en) | 2021-06-10 | 2023-04-04 | Belhaven BioPharma Inc. | Dry powder formulations of epinephrine and associated methods |
GB202117016D0 (en) | 2021-11-25 | 2022-01-12 | Orexo Ab | New pharmaceutical device |
GB202117007D0 (en) | 2021-11-25 | 2022-01-12 | Orexo Ab | New pharmaceutical composition |
AR127780A1 (es) | 2021-11-25 | 2024-02-28 | Orexo Ab | Nueva composición farmacéutica que comprende adrenalina |
GB202117015D0 (en) | 2021-11-25 | 2022-01-12 | Orexo Ab | New pharmaceutical composition |
US20230210722A1 (en) * | 2021-12-29 | 2023-07-06 | Baxter International, Inc. | Epinephrine premix formulations and uses thereof |
WO2024031148A1 (en) * | 2022-08-11 | 2024-02-15 | De Motu Cordis Pty Ltd | Inhalable epinephrine formulation |
Family Cites Families (38)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3095355A (en) * | 1961-10-12 | 1963-06-25 | Revlon | Aerosol composition |
US4069819A (en) | 1973-04-13 | 1978-01-24 | Societa Farmaceutici S.P.A. | Inhalation device |
US4352789A (en) | 1980-03-17 | 1982-10-05 | Minnesota Mining And Manufacturing Company | Aerosol compositions containing finely divided solid materials |
US4511258A (en) | 1983-03-25 | 1985-04-16 | Koflo Corporation | Static material mixing apparatus |
US4959358A (en) | 1983-06-06 | 1990-09-25 | Beth Israel Hospital Assn. | Drug administration |
US5192528A (en) * | 1985-05-22 | 1993-03-09 | Liposome Technology, Inc. | Corticosteroid inhalation treatment method |
US5002973A (en) | 1987-12-28 | 1991-03-26 | Dey Laboratories, Inc. | Stabilized sulfite-free catecholamine compositions |
US4906476A (en) | 1988-12-14 | 1990-03-06 | Liposome Technology, Inc. | Novel liposome composition for sustained release of steroidal drugs in lungs |
IT1228459B (it) | 1989-02-23 | 1991-06-19 | Phidea S R L | Inalatore con svuotamento regolare e completo della capsula. |
AU643435B2 (en) | 1989-04-28 | 1993-11-18 | Riker Laboratories, Inc. | Dry powder inhalation device |
GB8921222D0 (en) * | 1989-09-20 | 1989-11-08 | Riker Laboratories Inc | Medicinal aerosol formulations |
US6119688A (en) | 1991-08-26 | 2000-09-19 | 3M Innovative Properties Company | Powder dispenser |
AU5171293A (en) | 1992-10-14 | 1994-05-09 | Regents Of The University Of Colorado, The | Ion-pairing of drugs for improved efficacy and delivery |
SE9203743D0 (sv) | 1992-12-11 | 1992-12-11 | Astra Ab | Efficient use |
EP1462096B1 (en) | 1994-03-07 | 2008-12-10 | Nektar Therapeutics | Methods and compositions for pulmonary delivery of insulin |
GB9404945D0 (en) | 1994-03-15 | 1994-04-27 | Glaxo Group Ltd | Pharmaceutical composition |
US6102036A (en) * | 1994-04-12 | 2000-08-15 | Smoke-Stop | Breath activated inhaler |
DE4425255A1 (de) | 1994-07-16 | 1996-01-18 | Asta Medica Ag | Formulierung zur inhalativen Applikation |
US5612053A (en) | 1995-04-07 | 1997-03-18 | Edward Mendell Co., Inc. | Controlled release insufflation carrier for medicaments |
SE9501384D0 (sv) | 1995-04-13 | 1995-04-13 | Astra Ab | Process for the preparation of respirable particles |
US6309671B1 (en) * | 1995-04-14 | 2001-10-30 | Inhale Therapeutic Systems | Stable glassy state powder formulations |
GB9610821D0 (en) | 1996-05-23 | 1996-07-31 | Glaxo Wellcome Inc | Metering apparatus |
US5985309A (en) | 1996-05-24 | 1999-11-16 | Massachusetts Institute Of Technology | Preparation of particles for inhalation |
US5855913A (en) | 1997-01-16 | 1999-01-05 | Massachusetts Instite Of Technology | Particles incorporating surfactants for pulmonary drug delivery |
GB9616047D0 (en) | 1996-07-31 | 1996-09-11 | Glaxo Group Ltd | Medicament carrier with agglomerated large medicament particles and related method of manufacture thereof |
JP2001511160A (ja) * | 1997-02-05 | 2001-08-07 | ヤゴ リサーチ アクチェンゲゼルシャフト | 医学用エアゾール配合物 |
US6126919A (en) | 1997-02-07 | 2000-10-03 | 3M Innovative Properties Company | Biocompatible compounds for pharmaceutical drug delivery systems |
US6565885B1 (en) * | 1997-09-29 | 2003-05-20 | Inhale Therapeutic Systems, Inc. | Methods of spray drying pharmaceutical compositions |
US6284282B1 (en) * | 1998-04-29 | 2001-09-04 | Genentech, Inc. | Method of spray freeze drying proteins for pharmaceutical administration |
GB9810126D0 (zh) | 1998-05-13 | 1998-07-08 | Glaxo Group Ltd | |
US20020009478A1 (en) * | 1998-08-24 | 2002-01-24 | Douglas Joseph Dobrozsi | Oral liquid mucoadhesive compositions |
US6858199B1 (en) * | 2000-06-09 | 2005-02-22 | Advanced Inhalation Research, Inc. | High efficient delivery of a large therapeutic mass aerosol |
US20010036481A1 (en) | 1999-08-25 | 2001-11-01 | Advanced Inhalation Research, Inc. | Modulation of release from dry powder formulations |
US6613308B2 (en) * | 2000-09-19 | 2003-09-02 | Advanced Inhalation Research, Inc. | Pulmonary delivery in treating disorders of the central nervous system |
US6766799B2 (en) | 2001-04-16 | 2004-07-27 | Advanced Inhalation Research, Inc. | Inhalation device |
US6645293B2 (en) * | 2002-03-07 | 2003-11-11 | Illinois Institute Of Technology | Molecular crystals of controlled size |
US7008644B2 (en) | 2002-03-20 | 2006-03-07 | Advanced Inhalation Research, Inc. | Method and apparatus for producing dry particles |
CA2488976C (en) * | 2002-06-28 | 2009-08-25 | Advanced Inhalation Research, Inc. | Inhalable epinephrine |
-
2003
- 2003-06-26 CA CA002488976A patent/CA2488976C/en not_active Expired - Lifetime
- 2003-06-26 EP EP03742233.4A patent/EP1531794B1/en not_active Expired - Lifetime
- 2003-06-26 US US10/607,571 patent/US7947742B2/en active Active
- 2003-06-26 WO PCT/US2003/020166 patent/WO2004002551A2/en not_active Application Discontinuation
- 2003-06-26 PT PT37422334T patent/PT1531794T/pt unknown
- 2003-06-26 LT LTEP03742233.4T patent/LT1531794T/lt unknown
- 2003-06-26 DK DK03742233.4T patent/DK1531794T3/en active
- 2003-06-26 HU HUE03742233A patent/HUE033319T2/en unknown
- 2003-06-26 SI SI200332540T patent/SI1531794T1/sl unknown
- 2003-06-26 ES ES17170191T patent/ES2867378T3/es not_active Expired - Lifetime
- 2003-06-26 EP EP17170191.5A patent/EP3308772B8/en not_active Expired - Lifetime
- 2003-06-26 ES ES03742233.4T patent/ES2638987T3/es not_active Expired - Lifetime
- 2003-06-26 AU AU2003280102A patent/AU2003280102B2/en not_active Expired
-
2011
- 2011-04-08 US US13/082,626 patent/US8415397B2/en not_active Expired - Lifetime
-
2013
- 2013-03-06 US US13/787,026 patent/US8747813B2/en not_active Expired - Lifetime
-
2014
- 2014-05-01 US US14/267,401 patent/US20150094378A1/en not_active Abandoned
-
2016
- 2016-12-23 US US15/389,614 patent/US20170119699A1/en not_active Abandoned
-
2017
- 2017-08-10 CY CY20171100866T patent/CY1119481T1/el unknown
-
2018
- 2018-10-25 HK HK18113066.2A patent/HK1253918A1/zh not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
EP1531794A2 (en) | 2005-05-25 |
AU2003280102A1 (en) | 2004-01-19 |
ES2638987T3 (es) | 2017-10-25 |
US8415397B2 (en) | 2013-04-09 |
AU2003280102B2 (en) | 2007-01-25 |
DK1531794T3 (en) | 2017-08-28 |
US20130253065A1 (en) | 2013-09-26 |
PT1531794T (pt) | 2017-09-14 |
SI1531794T1 (sl) | 2017-12-29 |
US7947742B2 (en) | 2011-05-24 |
US20110237681A1 (en) | 2011-09-29 |
US20170119699A1 (en) | 2017-05-04 |
WO2004002551A3 (en) | 2004-08-12 |
CA2488976C (en) | 2009-08-25 |
EP1531794B1 (en) | 2017-05-10 |
EP3308772A1 (en) | 2018-04-18 |
ES2867378T8 (es) | 2022-02-10 |
HUE033319T2 (en) | 2017-11-28 |
US8747813B2 (en) | 2014-06-10 |
EP1531794A4 (en) | 2011-03-16 |
CY1119481T1 (el) | 2018-03-07 |
US20040076588A1 (en) | 2004-04-22 |
WO2004002551A2 (en) | 2004-01-08 |
US20150094378A1 (en) | 2015-04-02 |
CA2488976A1 (en) | 2004-01-08 |
EP3308772B1 (en) | 2021-01-13 |
LT1531794T (lt) | 2017-08-25 |
ES2867378T3 (es) | 2021-10-20 |
EP3308772B8 (en) | 2021-03-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1253918A1 (zh) | 可吸入腎上腺素 | |
PL372902A1 (en) | New use | |
GB0206048D0 (en) | Use | |
GB0227666D0 (en) | Use | |
AU154760S (en) | Inhaler | |
GB0207015D0 (en) | Interface | |
HK1145463A1 (en) | Remedy | |
AU2003287406A8 (en) | Digital-rights management | |
GB2384332B (en) | Computer configuration | |
GB0217056D0 (en) | Use | |
GB0213878D0 (en) | Use | |
GB0206838D0 (en) | Use | |
AU153471S (en) | Inhaler | |
AU153470S (en) | Inhaler | |
GB0230343D0 (en) | Use | |
AU152923S (en) | Inhaler | |
AU152926S (en) | Inhaler | |
AU152924S (en) | Inhaler | |
AU152925S (en) | Inhaler | |
GB0229442D0 (en) | Use | |
AU153472S (en) | Inhaler | |
AU153469S (en) | Inhaler | |
PL372417A1 (en) | Inhaler | |
GB0203207D0 (en) | New use | |
GB0218422D0 (en) | New use |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PE | Patent expired |
Effective date: 20230625 |